Literature DB >> 11137095

Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics.

F L Ubels1, J H Muntinga, J J van Doormaal, W D Reitsma, A J Smit.   

Abstract

Several studies have demonstrated the beneficial effects of 3 hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on vascular properties, but little is known about treatment intensification. We compared patients in whom statins were started (INITIAL, n=30) for hypercholesterolaemia (>6.5 mmol l(-1)) with a matched patient group of long-time statin users, with similar baseline characteristics for lipids, intima-media thickness (IMT), and pulse wave velocity, in whom treatment with statins was intensified (LONG-TERM, n=54). At baseline and after 1 year, lipid profile, IMT of the carotid and femoral arteries, aortic distensibility using pulse-wave velocity and various properties of the peripheral vascular bed using a recently developed bio-impedance method were measured. After 1 year the relative changes in lipid profile were significantly better in the INITIAL compared with the LONG-TERM-group. The relative changes in IMT of the mean internal carotid and common femoral arteries significantly differed between the INITIAL and LONG-TERM-group (-8 and +11%, -11 and +22%, respectively). After 1 year, in both groups, most other vascular wall characteristics were unaltered compared with baseline. In conclusion, the beneficial structural alterations of the vascular wall were greater after starting than after intensifying already existing lipid-lowering treatment. This suggests that other effects of HMG-CoA reductase inhibitors than lipid-lowering alone must be involved in vascular changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137095     DOI: 10.1016/s0021-9150(00)00450-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women.

Authors:  N Tentolouris; G Christodoulakos; I Lambrinoudaki; E Mandalaki; C Panoulis; C Maridaki; G Creatsas; N Katsilambros
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

2.  Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.

Authors:  Adam G Goodwill; Stephanie J Frisbee; Phoebe A Stapleton; Milinda E James; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

3.  Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction.

Authors:  Dalane W Kitzman; David M Herrington; Peter H Brubaker; J Brian Moore; Joel Eggebeen; Mark J Haykowsky
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

4.  Effects of Low Dose versus High Dose Statin Therapy on the Changes of Endothelial Function and Carotid Intima-Media Thickness in Patients with Variant Angina.

Authors:  Kye Hun Kim; Sook Hee Cho; Yi Rang Yim; Kyung Jin Lee; Ju Hyup Yum; Hyun Ju Yoon; Nam Sik Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  J Cardiovasc Ultrasound       Date:  2013-06-26

Review 5.  Repositioned Drugs for COVID-19-the Impact on Multiple Organs.

Authors:  Sean T Foster; Kayla G Chan; Matthew J Cacace; Shay L Ladd; Christina Chan; Caleb T Sandum; Paul T Wright; Brett Volmert; Weiyang Yang; Aitor Aguirre; Wen Li; Neil T Wright
Journal:  SN Compr Clin Med       Date:  2021-04-21

6.  Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.

Authors:  Eirik Ikdahl; Silvia Rollefstad; Jonny Hisdal; Inge C Olsen; Terje R Pedersen; Tore K Kvien; Anne Grete Semb
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.